Patrick M. Shea
Amministratore Delegato presso Intrance Medical Systems, Inc.
Profilo
Patrick M.
Shea is currently the Chief Executive Officer & Director at Intrance Medical Systems, Inc. He previously worked as a Director at OSI Pharmaceuticals, Inc.
Posizioni attive di Patrick M. Shea
Società | Posizione | Inizio |
---|---|---|
Intrance Medical Systems, Inc.
Intrance Medical Systems, Inc. Pharmaceuticals: MajorHealth Technology Intrance Medical Systems, Inc. is a company focused on developing and commercializing clinical products for the treatment of advanced Parkinson's disease. The company is based in Albany, NY. Recently, the company appointed Ashley Prange as Vice President of Business Development to strengthen its focus on strategic partnerships, including out-licensing activities and commercial collaborations. Parkinson's disease is the second most common neurodegenerative disorder, affecting nearly one million people in the United States. The company was founded in 2018 by Ulf Rosén and Roger Bolsöy. The CEO is Patrick M. Shea. | Amministratore Delegato | 13/05/2021 |
Precedenti posizioni note di Patrick M. Shea
Società | Posizione | Fine |
---|---|---|
OSI PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Intrance Medical Systems, Inc.
Intrance Medical Systems, Inc. Pharmaceuticals: MajorHealth Technology Intrance Medical Systems, Inc. is a company focused on developing and commercializing clinical products for the treatment of advanced Parkinson's disease. The company is based in Albany, NY. Recently, the company appointed Ashley Prange as Vice President of Business Development to strengthen its focus on strategic partnerships, including out-licensing activities and commercial collaborations. Parkinson's disease is the second most common neurodegenerative disorder, affecting nearly one million people in the United States. The company was founded in 2018 by Ulf Rosén and Roger Bolsöy. The CEO is Patrick M. Shea. | Health Technology |
- Borsa valori
- Insiders
- Patrick M. Shea